Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-11-06

FDA Approved: JINTELI — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approves JINTELI as an original generic application for a norethindrone acetate and ethinyl estradiol contraceptive, submitted by Teva Pharmaceuticals USA, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • JINTELI (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)

Snippet

ORIG AP for JINTELI (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)